此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year. (B1851065)

2018年11月30日 更新者:Pfizer
Serotype distribution and estimation of antimicrobial resistance in S. pneumoniae isolates and anticipated PCV7 and PCV13 coverage is difficult in Greece, because invasive isolates collected each year are limited and depict a certain proportion of patients who have easy access to tertiary care or have underlying medical reasons which necessitate inpatient care. It is also probable that the real burden of pneumococcal disease is not well estimated especially among adults. New additions in the laboratory setting such as the pneumococcal urine antigen assay (Binax NOW®) and the Urinary Antigen Diagnostic Assay (Luminex) for the detection of 13 serotype specific polysaccharides in human urine developed by Pfizer might be helpful in identifying more pneumococcal infections compared to the previous years. This NIS is based on the unmet scientific need to describe the serotype distribution and the resistance profile of isolates from X-Ray confirmed CAP in the present circumstances.

研究概览

地位

完全的

详细说明

For each surveillance period lasting for 12 months all adults presenting in the selected clinics with symptoms and signs suggestive of pneumonia (candidate cases) will be asked to participate in the study

研究类型

观察性的

注册 (实际的)

293

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Alexandroupoli、希腊、68100
        • General University Hospital of Alexandroupoli
      • Athens、希腊、11527
        • General Chest Diseases Hospital "Sotiria"/ 7th Department of Pulmonary Medicine
      • Athens、希腊、11527
        • General Hospital of Athens "Sotiria"/ 12Th Pneumonology Clinic
      • Athens、希腊、11527
        • General Hospital of Athens "Sotiria"/ 1St Pneumonology Clinic
      • Athens、希腊、11527
        • General Hospital of Athens "Sotiria"/ 2Nd Pneumonology Clinic
      • Athens、希腊、11527
        • General Hospital of Athens "Sotiria"/ 5Th Pneumonology Clinic
      • Athens、希腊、11527
        • General Hospital of Athens "Sotiria"/ 6Th Pneumonology Clinic
      • Athens、希腊、11527
        • General Hospital of Athens "Sotiria"/ 8Th Pneumonology Clinic
      • Athens、希腊、15123
        • Diagnostic Therapeutic Center of Athens Ygeia
      • Athens、希腊、15126
        • General Hospital Athens "Sismanoglio"/ 1St Pneumonology Clinic
      • Athens、希腊、15126
        • General Hospital of Athens "Sismanoglio" / 3Rd Pneumonology Department
      • Athens、希腊、15126
        • General Hospital of Athens "Sismanoglio"/ 2Nd Pneumonology Clinic
      • Athens、希腊、15127
        • General Hospital Mellision "Amalia Fleming"/ Pneumonology Clinic
      • Athens、希腊、15127
        • General Hospital Mellision "Amalia Fleming"/2nd Internal Medicine Department
      • Athens、希腊、15227
        • Sotiria Hospital, Intensive Care Unit
      • Athnens、希腊
        • General University Hospital "Attikgeneral University Hospital "Attikon"/ 4Th University Internal Med
      • Kavala、希腊、65201
        • General Hospital of Kavala/ A Pneumonological Clinic
      • Kavala、希腊、65201
        • General Hospital of Kavala/ b Pneumonological & Tubeculosis Department
      • Larissa、希腊、41 110
        • University General Hospial of Larissa, Pneumonology Department
    • Attiki
      • Athens、Attiki、希腊
        • General Hospital of Athens "Evangelismos" / Pneumonology Department
    • Evros
      • Alexandroupoli、Evros、希腊、68100
        • University Hospital of Alexandroupolis

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Adults ≥18 years of age with chest X-ray confirmed CAP

描述

Inclusion Criteria:

  • Patients who agreed to participate in the study and agreed to sign an ICD.
  • Patients had to be ≥18 years of age (adults)
  • Patients had to present or had been referred to a participating healthcare facility with suspected pneumonia based on the physician's assessment (including but not limited to specific signs and symptoms described in Section 9.3 of the protocol)
  • Patients must have had a posteroanterior or anteroposterior chest X-ray showing an infiltrate (if previous films were not available) or a new infiltrate (if recent film was available)
  • Patients had to be tested positive for the Binax NOW® assay (required post Protocol Amendment 2)

Exclusion Criteria:

  • Patients who did not sign an ICD.
  • Any patient who developed signs and symptoms of pneumonia after being hospitalized for ≥48 hours
  • Any patient who was transferred to a study healthcare facility after already being hospitalized for ≥48 hours at another healthcare facility
  • Patients who did not have a chest X-ray performed
  • Patients who did not have the Binax NOW® assay performed
  • Patients with negative results for the Binax NOW® assay (required post Protocol Amendment 2)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:仅案例
  • 时间观点:预期

队列和干预

团体/队列
干预/治疗
Group one
Adults ≥18 years of age with chest X-ray confirmed CAP
This Is A Non Interventional Study

研究衡量的是什么?

主要结果指标

结果测量
大体时间
The frequency of serotypes 4,6B,9V,14,18C,19F,23F,1,3,5,6A,7F and 19A from chest X-ray confirmed pCAP patients (post amendment2 with positive Binax NOW® only) who presented in the emergency departments of 15 hospitals in Greece during 1
大体时间:One year
One year
calendar year.
大体时间:One year
One year

次要结果测量

结果测量
大体时间
Susceptibility, resistance or partial resistance Streptococcus pneumoniae clinical isolates obtained from study adult CAP patients.
大体时间:One year
One year
The frequency of the 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 3, 5, 6A, 7F, 19A serotypes (based on Luminex assay) of study patients immunized and not immunized with PPV.
大体时间:One year
One year

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2011年1月1日

初级完成 (实际的)

2013年4月1日

研究完成 (实际的)

2013年4月1日

研究注册日期

首次提交

2012年3月26日

首先提交符合 QC 标准的

2012年3月27日

首次发布 (估计)

2012年3月28日

研究记录更新

最后更新发布 (实际的)

2018年12月3日

上次提交的符合 QC 标准的更新

2018年11月30日

最后验证

2018年11月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅